In CRC, KRAS is the most frequent isoform mutation, accounting for about 20% of all human cancers, while neuroblastoma rat sarcoma (NRAS) and Harvey rat sarcoma (HRAS) mutations are found in about 8% and 3% of cancers, respectively [66]. This evidence concerns the gene HRAS and cancer.